Ikonisys has acquired 1 company, including 1 in the last 5 years.
Ikonisys’ largest acquisition to date was in 2023, when it acquired Hospitex International Srl for $5M. The Company’s most targeted sectors include medical products (100%).
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2023-11-23 |
Hospitex · Medical Products
Florence, France · www.hospitex.com Hospitex is a Thin Layer Cytology and Cancer Diagnostics company that provides laboratory instrumentations in cytology and has developed a unique patented platform for slide preparation called Nephelometric Smart Technology (NST). It provides advanced solutions for very accurate standardized single-layer liquid-based cytology (LBC) slides. This cutting-edge technology enables the company to produce thin-layer diagnostic slides for any organ targeted. Hospitex is based in Florence, France.
|
5
2.5x REVENUE |
Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
